<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00492947</url>
  </required_header>
  <id_info>
    <org_study_id>HP-00040999</org_study_id>
    <nct_id>NCT00492947</nct_id>
  </id_info>
  <brief_title>Dendritic Cell Vaccine for Head and Neck Cancer</brief_title>
  <acronym>Dendritic</acronym>
  <official_title>0608 GCC:Phase I Study of Intra-tumoral Injection of Dendritic Cells for the Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Maryland, Baltimore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Maryland, Baltimore</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research study is testing a new treatment of cancer of the head and neck.&#xD;
&#xD;
      Purpose&#xD;
&#xD;
      This research study is being done to:&#xD;
&#xD;
        1. Test the safety of the experimental cancer vaccine made of dendritic cells. An&#xD;
           experimental vaccine is one that is not approved by the Food and Drug Administration&#xD;
           (FDA).&#xD;
&#xD;
        2. To learn what effects (good and bad) the vaccine will have on you and your head and neck&#xD;
           cancer.&#xD;
&#xD;
        3. To learn if the vaccine will stimulate your body's white blood cells, which are part of&#xD;
           your immune system (your body's natural defense system).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      White blood cells are part of the body's defense system. Sometimes when you have cancer, your&#xD;
      body does not know that the cancer cells are making you sick. We hope to teach your white&#xD;
      blood cells to find and destroy your cancer cells with a vaccine. The vaccine will be made&#xD;
      from a special kind of blood cell called a dendritic cell. This is the cell that will carry&#xD;
      the information about your cancer to your white blood cells in your body.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    major amendments in progress&#xD;
  </why_stopped>
  <start_date>June 2007</start_date>
  <completion_date type="Anticipated">June 2012</completion_date>
  <primary_completion_date type="Anticipated">June 2010</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>safety</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Efficacy as measured by RECIST criteria</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Characterize the immune response to the vaccine</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">0</enrollment>
  <condition>Squamous Cell Carcinoma of Head and Neck</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>dendritic cell vaccine</intervention_name>
    <description>3 vaccinations total: Day 10, Day 20, Day 30</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Squamous cell carcinoma of the head and neck in patients with unresectable recurrent&#xD;
             disease or distant metastasis or patients who fail conventional radiation therapy&#xD;
             and/or chemotherapy and refuse surgical salvage.&#xD;
&#xD;
          -  Presence of cervical metastasis that is able to be accessed for injection&#xD;
&#xD;
          -  Biopsy accessible tumor (metastatic or primary)&#xD;
&#xD;
          -  &gt;18 years of age.&#xD;
&#xD;
          -  The following laboratory values obtained ≤14 days prior to registration:&#xD;
&#xD;
               -  ANC ≥1500&#xD;
&#xD;
               -  PLT ≥100,000&#xD;
&#xD;
               -  Hgb ≥ 9.0 g/dL&#xD;
&#xD;
               -  Alkaline phosphatase ≤3 x UNL&#xD;
&#xD;
               -  AST ≤3 x UNL&#xD;
&#xD;
               -  Creatinine ≤1.5 x UNL&#xD;
&#xD;
          -  Life expectancy ≥6 months.&#xD;
&#xD;
          -  ECOG performance status 0, 1, or 2.&#xD;
&#xD;
          -  No chemotherapy for prior 4 weeks.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant women.&#xD;
&#xD;
          -  Nursing women.&#xD;
&#xD;
          -  Men or women of childbearing potential who are unwilling to employ adequate&#xD;
             contraception (condoms, diaphragm, birth control pills, injections, intrauterine&#xD;
             device {IUD}, abstinence.)&#xD;
&#xD;
          -  Known HIV infection.&#xD;
&#xD;
          -  Concurrent use of systemic immunosuppressants.&#xD;
&#xD;
          -  Other immunocompromising condition that in the opinion of the physician renders the&#xD;
             patient a poor candidate for this trial.&#xD;
&#xD;
          -  Other active cancer requiring therapy to control the disease.&#xD;
&#xD;
          -  Unwillingness to return for follow-up evaluations over a period of up to 2 years&#xD;
             following completion of protocol therapy.&#xD;
&#xD;
          -  Other intercurrent medical problems that, in the opinion of the investigator, would&#xD;
             make participation in the study hazardous for the patient&#xD;
&#xD;
          -  Patients in whom the otolaryngologist, radiation oncologist, and medical oncologist&#xD;
             can not agree on a consensus node to treat.&#xD;
&#xD;
          -  Patients with CNS metastasis or involvement of sites where an inflammatory response&#xD;
             would constitute an immediately life threatening situation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey Wolf, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Maryland, College Park</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Maryland Dept. of Otorhinolaryngology</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>June 26, 2007</study_first_submitted>
  <study_first_submitted_qc>June 26, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2007</study_first_posted>
  <last_update_submitted>April 27, 2021</last_update_submitted>
  <last_update_submitted_qc>April 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Phase I</keyword>
  <keyword>dendritic cell</keyword>
  <keyword>vaccine</keyword>
  <keyword>intra tumoral</keyword>
  <keyword>squamous cell carcinoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Squamous Cell</mesh_term>
    <mesh_term>Squamous Cell Carcinoma of Head and Neck</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

